title: [The bioresorbable coronary stent: a revolution].
abstract: Coronary angioplasty has undergone several technological revolutions: starting with balloon angioplasty, then with bare metal stent and finally with drug eluting stent (DES), this technique is now mature. However, once we thought the problem of instent restenosis solved with DES, new concerns arise with late and very late stent thrombosis. Should we therefore proscribe DES? How long should be the duration of dual antiplatelet therapy? And how should we manage the patients who need a surgery and are at high risk of bleeding? Are bioresorbable stents the final solution with their initial mechanical properties, then with their drug eluting effect against intra-stent restenosis, and finally with their complete resorption which leaves the artery free of any foreign material?
authors: Service de médecine interne, Hôpital de La Tour, Avenue J.-D. Maillard 3 1217 Meyrin/Genève. flora.koegler@latour.ch
authors: Flora
authors: F
authors: Koegler
authors: Edoardo
authors: E
authors: De Benedetti
mesh_terms: D020341:Absorbable Implants; D015906:Angioplasty, Balloon, Coronary / Q000295:instrumentation / Q000379:methods; D023903:Coronary Restenosis / Q000209:etiology / Q000517:prevention & control; D003328:Coronary Thrombosis / Q000209:etiology / Q000517:prevention & control; D054855:Drug-Eluting Stents; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage; D015607:Stents; D013997:Time Factors
chemical_list: D010975:Platelet Aggregation Inhibitors